Free Trial
→ From the man who predicted 2008 crash… (From Porter & Company) (Ad)tc pixel Free KLXE Stock Alerts

KLX Energy Services (KLXE) Short Interest Ratio & Short Volume

KLX Energy Services logo
$4.14 -0.14 (-3.16%)
As of 02:04 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

KLX Energy Services Short Interest Overview

As of April 30, 2026, KLX Energy Services (KLXE) had a short interest of 1.29 million shares sold short, representing 6.93% of the public float. This marks a -6.18% decrease in short interest since the prior report. The short interest ratio (days to cover) is 3.7, meaning it would take 3.7 days of the average trading volume of 281,883 shares to cover all short positions.

Current Short Interest
1,288,296 shares
Previous Short Interest
1,373,174 shares
Change Vs. Previous Month
-6.18%
Dollar Volume Sold Short
$4.81 million
Short Interest Ratio
3.7 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
19,669,000 shares
Short Percent of Float
6.93%
Today's Trading Volume
281,492 shares
Average Trading Volume
281,883 shares
Today's Volume Vs. Average
100%
Short Selling KLX Energy Services?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for KLX Energy Services and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

KLXE Short Interest Over Time

KLXE Days to Cover Over Time

KLXE Percentage of Float Shorted Over Time

KLX Energy Services Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20261,288,296 shares $4.81 million -6.2%6.9%3.71 $3.73
4/15/20261,373,174 shares $3.16 million -8.2%7.4%4.89 $2.30
3/31/20261,496,267 shares $3.89 million -7.0%8.0%5.85 $2.60
3/13/20261,608,576 shares $4.33 million +6.0%8.7%3.87 $2.69
2/27/20261,517,000 shares $3.85 million +3.7%9.0%7.56 $2.54
2/13/20261,462,422 shares $3.71 million +12.9%8.7%7.99 $2.54
1/30/20261,295,399 shares $3.60 million -1.7%7.7%4.48 $2.78
1/15/20261,318,043 shares $2.79 million +0.2%7.8%5.59 $2.12
12/31/20251,315,397 shares $2.49 million -4.8%7.8%5.42 $1.89
12/15/20251,382,215 shares $2.42 million +2.9%8.2%8.52 $1.75
11/28/20251,343,794 shares $2.23 million +8.8%8.0%9.82 $1.66
11/14/20251,235,626 shares $2.03 million +1.2%7.3%9.31 $1.64
10/31/20251,221,598 shares $2.28 million -10.5%7.2%10.54 $1.87
10/15/20251,360,000 shares $2.45 million -8.1%8.0%13.1 $1.80
9/30/20251,480,000 shares $2.84 million -9.8%N/A12.5 $1.92
9/15/20251,640,000 shares $2.94 million -17.6%N/A12.6 $1.79
8/31/20251,990,000 shares $3.90 million +22.1%11.8%11.1 $1.96
8/15/20251,630,000 shares $2.98 million +1.2%N/A9.1 $1.83
7/31/20251,610,000 shares $2.88 million +6.6%9.5%8.2 $1.79
7/15/20251,510,000 shares $2.39 million -8.5%N/A7.7 $1.59
6/30/20251,650,000 shares $3.09 million +17.0%9.9%7.5 $1.87
6/15/20251,410,000 shares $3.98 million -14.0%8.5%6.1 $2.82
5/31/20251,640,000 shares $2.84 million +3.8%10.1%8.5 $1.73
5/15/20251,580,000 shares $3.35 million +14.5%9.7%7.2 $2.12
4/30/20251,380,000 shares $2.77 million -6.8%N/A6.4 $2.01
4/15/20251,480,000 shares $2.47 million -5.1%9.1%6.8 $1.67
3/31/20251,560,000 shares $5.46 million +3.3%9.6%7.2 $3.50
3/15/20251,510,000 shares $6.40 million -10.7%9.3%8.4 $4.24
2/28/20251,690,000 shares $7.89 million +12.7%10.4%10.1 $4.67
2/15/20251,500,000 shares $7.07 million +7.1%9.2%10.4 $4.71
1/31/20251,400,000 shares $7.41 million -2.1%N/A9.5 $5.29
1/15/20251,430,000 shares $8.24 million -3.4%N/A10.3 $5.76
12/31/20241,480,000 shares $7.37 million +8.8%N/A12.7 $4.98
12/15/20241,360,000 shares $6.56 million -0.7%N/A12.4 $4.82
11/30/20241,370,000 shares $8.26 million -0.7%N/A12.2 $6.03
11/15/20241,380,000 shares $7.51 million +0.7%N/A11.6 $5.44
10/31/20241,370,000 shares $6.06 million -3.5%N/A10.7 $4.42
10/15/20241,420,000 shares $7.38 million -7.8%N/A10.8 $5.20
9/30/20241,540,000 shares $8.42 million +18.5%N/A11 $5.47
9/15/20241,300,000 shares $6.51 million -3.0%N/A7.3 $5.01
NNVC FDA = New Momentum Wave! (Ad)

NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance.tc pixel

See why this FDA milestone could be a catalyst for NNVC
8/31/20241,340,000 shares $9.86 million -5.0%N/A7.2 $7.36
8/15/20241,410,000 shares $9.52 million -2.1%N/A7.4 $6.75
7/31/20241,440,000 shares $9.92 million -11.7%N/A6.9 $6.89
7/15/20241,630,000 shares $8.74 million -28.8%N/A7.6 $5.36
6/30/20242,290,000 shares $11.34 million +1.8%N/A10.3 $4.95
6/15/20242,250,000 shares $9.61 million +0.5%N/A10.9 $4.27
5/31/20242,240,000 shares $11.45 million -2.2%N/A10.3 $5.11
5/15/20242,290,000 shares $13.06 million +3.2%N/A9.8 $5.71
4/30/20242,220,000 shares $14.72 million +24.0%N/A10.4 $6.63
4/15/20241,790,000 shares $13.62 million -2.2%N/A9.2 $7.61
3/31/20241,830,000 shares $14.16 million +18.1%N/A10.4 $7.74
3/15/20241,550,000 shares $11.36 million +13.1%N/A9.7 $7.33
2/29/20241,370,000 shares $11.12 million +10.5%N/A9.9 $8.12
2/15/20241,240,000 shares $11.77 million +3.3%N/A10.6 $9.49
1/31/20241,200,000 shares $11.66 million -4.8%N/A10.1 $9.72
1/15/20241,260,000 shares $12.99 million +0.8%N/A10.8 $10.31
12/31/20231,250,000 shares $14.08 million -5.3%N/A10.3 $11.26
12/15/20231,320,000 shares $13.50 million +5.6%N/A9.7 $10.23
11/30/20231,250,000 shares $11.88 million +7.8%N/A9.3 $9.50
11/15/20231,160,000 shares $11.07 million +3.6%N/A7.8 $9.54
10/31/20231,120,000 shares $11.51 million -5.1%N/A6.9 $10.28
10/15/20231,180,000 shares $12.66 million +0.9%N/A7.3 $10.73
9/30/20231,170,000 shares $13.86 million -4.1%N/A6.8 $11.85
9/15/20231,220,000 shares $14.16 million -2.4%N/A7.2 $11.61
8/31/20231,250,000 shares $13.01 million +7.8%N/A5.8 $10.41
8/15/20231,160,000 shares $13.08 million -24.2%N/A5.3 $11.28
7/31/20231,530,000 shares $17.95 million -1.9%N/A6.6 $11.73
7/15/20231,560,000 shares $16.58 million +2.0%N/A6.5 $10.63
6/30/20231,530,000 shares $14.89 million +35.4%N/A6.4 $9.73
6/15/20231,130,000 shares $10.58 million +22.4%N/A4.8 $9.36
5/31/2023922,900 shares $7.33 million -16.1%N/A4.4 $7.94
5/15/20231,100,000 shares $11.46 million +23.0%N/A5.6 $10.42
4/30/2023894,400 shares $8.92 million +19.5%N/A4.8 $9.97
4/15/2023748,600 shares $8.52 million +15.5%N/A4.1 $11.38
3/31/2023648,300 shares $7.55 million +23.7%N/A3.4 $11.65
3/15/2023524,200 shares $6.50 million +4.0%N/A2.5 $12.40
2/28/2023504,000 shares $6.45 million -8.9%N/A2.5 $12.79
2/15/2023553,400 shares $7.54 million -12.3%N/A2.6 $13.62
1/31/2023630,800 shares $9.32 million +7.5%N/A2.5 $14.78
1/15/2023586,800 shares $9.44 million +0.9%N/A2.1 $16.09
12/30/2022581,400 shares $10.06 million -16.7%N/A2 $17.31
12/15/2022697,600 shares $10.23 million +8.5%N/A2.2 $14.67
11/30/2022642,900 shares $10.14 million -29.3%N/A2.1 $15.78
11/15/2022909,200 shares $15.47 million -20.3%N/A3 $17.02
10/31/20221,140,000 shares $17.54 million -0.9%N/A3.8 $15.39
10/15/20221,150,000 shares $10.72 million -4.2%N/A4.5 $9.32
9/30/20221,200,000 shares $9.88 million +6.2%N/A5.4 $8.23
9/15/20221,130,000 shares $7.82 million +5.6%N/A5.9 $6.92
8/31/20221,070,000 shares $8.13 million -3.6%N/A5.1 $7.60
8/15/20221,110,000 shares $7.98 million -3.5%N/A4.8 $7.19
NNVC FDA = New Momentum Wave! (Ad)

NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measles at a time when no approved antiviral treatments exist and cases are resurging globally. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, Mpox, and more - giving NNVC exposure to multiple large markets as Phase II trials advance.tc pixel

See why this FDA milestone could be a catalyst for NNVC
7/31/20221,150,000 shares $6.14 million -0.9%N/A5.1 $5.34
7/15/20221,160,000 shares $4.62 million -7.2%N/A4.8 $3.98
6/30/20221,250,000 shares $5.41 million +3.3%N/A4 $4.33
6/15/20221,210,000 shares $6.36 million -10.4%N/A3.2 $5.26
5/31/20221,350,000 shares $8.25 million -5.6%N/A3 $6.11
5/15/20221,430,000 shares $7.08 million -2.7%N/A2.1 $4.95
4/30/20221,470,000 shares $7.25 million +15.8%N/A2.2 $4.93
4/15/20221,270,000 shares $7.92 million +17.6%N/A1.8 $6.24
3/31/20221,080,000 shares $5.58 million +0.9%N/A1.6 $5.17
3/15/20221,070,000 shares $8.86 million -7.8%N/A1.7 $8.28
2/28/20221,160,000 shares $7.77 million +1.8%N/A2 $6.70
2/15/20221,140,000 shares $7.22 million -16.8%13.0%3.4 $6.33
1/31/20221,370,000 shares $6.84 million +13.2%15.7%3.9 $4.99
1/15/20221,210,000 shares $5.48 million -15.4%16.2%3.3 $4.53
12/31/20211,430,000 shares $4.43 million +12.6%19.8%3.7 $3.10
12/15/20211,270,000 shares $4.09 million +17.6%17.6%2.9 $3.22
11/30/20211,080,000 shares $4.32 million +1.9%15.0%2.7 $4.00
11/15/20211,060,000 shares $4.45 million -9.4%14.7%2.8 $4.20
10/29/20211,170,000 shares $5.12 million +24.6%16.2%3.4 $4.38
10/15/2021939,200 shares $4.35 million -4.3%13.0%3.2 $4.63
9/30/2021981,100 shares $4.67 million +12.3%13.6%4.3 $4.76
9/15/2021873,700 shares $4.59 million +0.3%12.9%6.9 $5.25
8/31/2021870,700 shares $5.54 million +7.9%11.7%6.1 $6.36
8/13/2021807,300 shares $4.13 million +5.0%13.5%5.5 $5.11
7/30/2021768,900 shares $4.58 million +8.1%12.9%5.3 $5.96
7/15/2021711,000 shares $4.99 million +3.2%12.1%4.2 $7.02
6/30/2021689,300 shares $6.58 million +2.4%14.1%3.3 $9.55
6/15/2021673,300 shares $6.49 million +18.1%13.8%3.3 $9.64
5/28/2021569,900 shares $6.76 million -6.4%11.7%3.1 $11.87
5/14/2021609,000 shares $7.28 million +14.5%12.5%3.3 $11.95

KLXE Short Interest - Frequently Asked Questions

Short interest is the volume of KLX Energy Services shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,288,296 shares of KLXE short. 6.93% of KLX Energy Services' shares are currently sold short. Learn More on KLX Energy Services' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KLXE shares currently have a short interest ratio of 3.7. Learn More on KLX Energy Services's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.93% of KLX Energy Services' floating shares are currently sold short.

KLX Energy Services saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 1,288,296 shares, a drop of 6.2% from the previous total of 1,373,174 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

6.93% of KLX Energy Services' shares are currently sold short. Here is how the short interest of companies in the industry of "petroleum and natural gas" compare to KLX Energy Services: Amplify Energy Corp. (7.83%), Kolibri Global Energy Inc. (2.18%), Epsilon Energy Ltd. (5.30%), Mammoth Energy Services, Inc. (1.83%), NCS Multistage Holdings, Inc. (0.78%), Prairie Operating Co. (21.43%), Permianville Royalty Trust (0.23%), VOC Energy Trust (0.27%), U.S. Energy Corp. (14.02%), PermRock Royalty Trust (0.71%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling KLXE is an investing strategy that aims to generate trading profit from KLX Energy Services as its price is falling. KLXE shares are trading down $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for KLX Energy Services occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KLXE, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KLXE, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like KLXE:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:KLXE) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
NNVC FDA = New Momentum Wave!
NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for its antiviral NV-387, targeting measl...
Equiscreen | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel